Exact Mass: 351.2158

Exact Mass Matches: 351.2158

Found 62 metabolites which its exact mass value is equals to given mass value 351.2158, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Sphingosine 1-phosphate (d16:1-P)

{[(2S,3R,4E)-2-amino-3-hydroxyhexadec-4-en-1-yl]oxy}phosphonic acid

C16H34NO5P (351.2174)


Sphingosine 1-phosphate (d16:1-P) is a Sphingosine-1-phosphate. Sphingosine-1-phosphate is a signaling sphingolipid. It is also referred to as a bioactive lipid mediator. Sphingolipids at large form a class of lipids characterized by a particular aliphatic aminoalcohol, which is sphingosine. (Wikipedia)

   

Pyrrolifene

1,2-Diphenyl-3-[(pyrrolidin-1-yl)methyl]butan-2-yl acetic acid

C23H29NO2 (351.2198)


   

N-[1-[4-[(4-Pyrimidin-2-ylpiperazin-1-yl)methyl]phenyl]cyclopropyl]acetamide

N-[1-(4-{[4-(pyrimidin-2-yl)piperazin-1-yl]methyl}phenyl)cyclopropyl]ethanimidate

C20H25N5O (351.2059)


   

mycoleptodiscin A

mycoleptodiscin A

C23H29NO2 (351.2198)


   

SCHEMBL4904327

SCHEMBL4904327

C23H29NO2 (351.2198)


   

D-erythro-MAPP

D-erythro-MAPP

C23H29NO2 (351.2198)


   

SPBP 16:1;O2

Hexadecaphing-4-enine-1-phosphate

C16H34NO5P (351.2174)


   
   

Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-cyclohexyl- (9CI)

Urea, N-[2-[(3-cyano-8-methyl-2-quinolinyl)amino]ethyl]-N-cyclohexyl- (9CI)

C20H25N5O (351.2059)


   

sebacic acid, compound with 2,2,2-nitrilotriethanol

sebacic acid, compound with 2,2,2-nitrilotriethanol

C16H33NO7 (351.2257)


   

Pyrrolifene

Pyrrolifene

C23H29NO2 (351.2198)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

1H-Benzimidazole,2-[1-[(1-cyclopentyl-1H-tetrazol-5-yl)methyl]-4-piperidinyl]-(9CI)

1H-Benzimidazole,2-[1-[(1-cyclopentyl-1H-tetrazol-5-yl)methyl]-4-piperidinyl]-(9CI)

C19H25N7 (351.2171)


   

Phenadoxone

6-morpholin-4-yl-4,4-diphenylheptan-3-one

C23H29NO2 (351.2198)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   
   

prostaglandin E2(1-)

prostaglandin E2(1-)

C20H31O5- (351.2171)


The conjugate base of prostaglandin E2; major species at pH 7.3.

   

prostaglandin I2(1-)

prostaglandin I2(1-)

C20H31O5- (351.2171)


D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Conjugate base of prostaglandin I2.

   

thromboxane A2(1-)

thromboxane A2(1-)

C20H31O5- (351.2171)


Conjugate base of thromboxane A2 arising from deprotonation of the carboxylic acid function. COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

prostaglandin D2(1-)

prostaglandin D2(1-)

C20H31O5- (351.2171)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin D2., obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5S,6E,8Z,10E,12E,14R,15S)-5,14,15-Trihydroxyicosa-6,8,10,12-tetraenoate

(5S,6E,8Z,10E,12E,14R,15S)-5,14,15-Trihydroxyicosa-6,8,10,12-tetraenoate

C20H31O5- (351.2171)


D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

prostaglandin H2(1-)

prostaglandin H2(1-)

C20H31O5- (351.2171)


Conjugate base of prostaglandin H2.

   

(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

(5S,6R,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C20H31O5- (351.2171)


   

15-dehydro-prostaglandin E1(1-)

15-dehydro-prostaglandin E1(1-)

C20H31O5- (351.2171)


Conjugate base of 15-dehydro-prostaglandin E1.

   

(5S,6Z,8E,10E,12R,14Z)-5,12,20-Trihydroxyicosa-6,8,10,14-tetraenoate

(5S,6Z,8E,10E,12R,14Z)-5,12,20-Trihydroxyicosa-6,8,10,14-tetraenoate

C20H31O5- (351.2171)


   

13,14-dihydro-15-oxo-prostaglandin E2(1-)

13,14-dihydro-15-oxo-prostaglandin E2(1-)

C20H31O5- (351.2171)


Conjugate base of 13,14-dihydro-15-oxo-prostaglandin E2.

   

(5S,15S)-5-hydroperoxy-15-HETE(1-)

(5S,15S)-5-hydroperoxy-15-HETE(1-)

C20H31O5- (351.2171)


5-hydroperoxy-15-HETE(1-) that has 5S,15S configuration. The conjugate base of (5S,15S)-5-hydroperoxy-15-HETE. The major species at pH 7.3.

   

15-dehydroprostaglandin F2alpha

15-dehydroprostaglandin F2alpha

C20H31O5- (351.2171)


   

6 epi-lipoxin A4

6 epi-lipoxin A4

C20H31O5- (351.2171)


   

15 epi-lipoxin B4

15 epi-lipoxin B4

C20H31O5- (351.2171)


   

15 epi-lipoxin A4

15 epi-lipoxin A4

C20H31O5- (351.2171)


   

(5S,7E,9E,11Z,13E,15S)-15-hydroperoxy-5-hydroxyicosa-7,9,11,13-tetraenoate

(5S,7E,9E,11Z,13E,15S)-15-hydroperoxy-5-hydroxyicosa-7,9,11,13-tetraenoate

C20H31O5- (351.2171)


   

(5S,6E,8Z,11Z,13E,15R)-5-hydroperoxy-15-hydroxyicosa-6,8,11,13-tetraenoate

(5S,6E,8Z,11Z,13E,15R)-5-hydroperoxy-15-hydroxyicosa-6,8,11,13-tetraenoate

C20H31O5- (351.2171)


   

20-hydroxy-6-trans-leukotriene B4(1-)

20-hydroxy-6-trans-leukotriene B4(1-)

C20H31O5- (351.2171)


A leukotriene anion that is the conjugate base of 20-hydroxy-6-trans-leukotriene B4 arising from deprotonation of the carboxylic acid function; major species at pH 7.3.

   

13,14-dihydro-15-oxolipoxin A4(1-)

13,14-dihydro-15-oxolipoxin A4(1-)

C20H31O5- (351.2171)


A hydroxy fatty acid anion obtained by deprotonation of the carboxy function of 13,14-dihydro-15-oxolipoxin A4; major species at pH 7.3.

   

(12S)-hydroperoxy-(14R,15S)-epoxy-(5Z,8Z,10E)-icosatrienoate

(12S)-hydroperoxy-(14R,15S)-epoxy-(5Z,8Z,10E)-icosatrienoate

C20H31O5- (351.2171)


A polyunsaturated fatty acid anion that is the conjugate base of (12S)-hydroperoxy-(14R,15S)-EET, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoate

(12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoate

C20H31O5- (351.2171)


A polyunsaturated fatty acid anion that is the conjugate base of (12S)-hydroperoxy-(14S,15R)-epoxy-(5Z,8Z,10E)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5S)-hydroperoxy-(14R,15S)-epoxy-(6E,8Z,11Z)-icosatrienoate

(5S)-hydroperoxy-(14R,15S)-epoxy-(6E,8Z,11Z)-icosatrienoate

C20H31O5- (351.2171)


A polyunsaturated fatty acid anion that is the conjugate base of (5S)-hydroperoxy-(14R,15S)-epoxy-(6E,8Z,11Z)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(8S)-hydroperoxy-(14S,15R)-epoxy-(5Z,9E,11Z)-icosatrienoate

(8S)-hydroperoxy-(14S,15R)-epoxy-(5Z,9E,11Z)-icosatrienoate

C20H31O5- (351.2171)


A polyunsaturated fatty acid anion that is the conjugate base of (8S)-hydroperoxy-(14S,15R)-epoxy-(5Z,9E,11Z)-icosatrienoate, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

20-hydroxy prostaglandin A1

20-hydroxy prostaglandin A1

C20H31O5- (351.2171)


   

6-(3,5-dimethyl-4-isoxazolyl)-N-[(1-methyl-2-piperidinyl)methyl]-4-quinazolinamine

6-(3,5-dimethyl-4-isoxazolyl)-N-[(1-methyl-2-piperidinyl)methyl]-4-quinazolinamine

C20H25N5O (351.2059)


   

(5S,6Z,8E,10E,12R,14Z)-5,12,19-trihydroxyicosa-6,8,10,14-tetraenoate

(5S,6Z,8E,10E,12R,14Z)-5,12,19-trihydroxyicosa-6,8,10,14-tetraenoate

C20H31O5- (351.2171)


   

(5S,6Z,8E,10E,12R,14Z)-5,12,18-trihydroxyicosa-6,8,10,14-tetraenoate

(5S,6Z,8E,10E,12R,14Z)-5,12,18-trihydroxyicosa-6,8,10,14-tetraenoate

C20H31O5- (351.2171)


   

(5S,6E,8Z,11Z,13E,15S)-15-hydroperoxy-5-hydroxyicosa-6,8,11,13-tetraenoate

(5S,6E,8Z,11Z,13E,15S)-15-hydroperoxy-5-hydroxyicosa-6,8,11,13-tetraenoate

C20H31O5- (351.2171)


   

(S,S)-5,12-HpHETE(1-)

(S,S)-5,12-HpHETE(1-)

C20H31O5- (351.2171)


   

5-hydroperoxy-15-HETE(1-)

5-hydroperoxy-15-HETE(1-)

C20H31O5- (351.2171)


An icosanoid anion that is the conjugate base of 5-hydroperoxy-15-HETE, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   
   

(5Z,13E,15S,17Z)-9alpha,11alpha,15-Trihydroxyprosta-5,13,17-trien-1-Oate

(5Z,13E,15S,17Z)-9alpha,11alpha,15-Trihydroxyprosta-5,13,17-trien-1-Oate

C20H31O5- (351.2171)


   

lipoxin B4(1-)

lipoxin B4(1-)

C20H31O5 (351.2171)


A hydroxy fatty acid anion obtained by the deprotonation of the carboxy group of lipoxin B4: major species at pH 7.3.

   

C16 Sphingosine-1-phosphate

C16 Sphingosine-1-phosphate

C16H34NO5P (351.2174)


   

19-hydroxyleukotriene B4(1-)

19-hydroxyleukotriene B4(1-)

C20H31O5 (351.2171)


A leukotriene anion that is the conjugate base of 19-hydroxyleukotriene B4, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5S)-hydroxy-(15S)-hydroperoxy-(6E,8Z,11Z,13E)-icosatetraenoate

(5S)-hydroxy-(15S)-hydroperoxy-(6E,8Z,11Z,13E)-icosatetraenoate

C20H31O5 (351.2171)


An hydroperoxy(hydroxy)icosatetraenoate that is the conjugate base of (5S)-hydroxy-(15S)-hydroperoxy-(6E,8Z,11Z,13E)-icosatetraenoic acid; major species at pH 7.3.

   

lipoxin A4(1-)

lipoxin A4(1-)

C20H31O5 (351.2171)


A hydroxy fatty acid anion obtained by deprotonation of the carboxy function of lipoxin A4: major species at pH 7.3.

   

18-hydroxyleukotriene B4(1-)

18-hydroxyleukotriene B4(1-)

C20H31O5 (351.2171)


A leukotriene anion that is the conjugate base of 18-hydroxyleukotriene B4, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

20-hydroxy-leukotriene B4(1-)

20-hydroxy-leukotriene B4(1-)

C20H31O5 (351.2171)


Conjugate base of 20-hydroxy-leukotriene B4 arising from deprotonation of the carboxylic acid function.

   

hexadecasphing-4-enine-1-phosphate

hexadecasphing-4-enine-1-phosphate

C16H34NO5P (351.2174)


A sphingoid 1-phosphate that is hexadecasphing-4-enine substituted by a phospho group at position 1.

   

C16 Sphingosine 1-phosphate

C16 Sphingosine 1-phosphate

C16H34NO5P (351.2174)


   

(1s,12s,15s,20r)-15-hydroxy-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-one

(1s,12s,15s,20r)-15-hydroxy-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-one

C23H29NO2 (351.2198)


   

(1e,3s,5z,10s,11r)-2,6,10-trimethyl-1-(2-methyl-1,3-thiazol-4-yl)trideca-1,5-diene-3,11-diol

(1e,3s,5z,10s,11r)-2,6,10-trimethyl-1-(2-methyl-1,3-thiazol-4-yl)trideca-1,5-diene-3,11-diol

C20H33NO2S (351.2232)


   

(2r,5s,10s,11r)-2,6,6,10-tetramethyl-15-azapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁰]icosa-1(19),13,16(20)-triene-17,18-dione

(2r,5s,10s,11r)-2,6,6,10-tetramethyl-15-azapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁰]icosa-1(19),13,16(20)-triene-17,18-dione

C23H29NO2 (351.2198)


   

(2e)-n-{4-[(3-aminopropyl)amino]butyl}-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enimidic acid

(2e)-n-{4-[(3-aminopropyl)amino]butyl}-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enimidic acid

C18H29N3O4 (351.2158)


   

15-hydroxy-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-one

15-hydroxy-1,16,16,20-tetramethyl-3-azapentacyclo[10.8.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]icosa-2(10),4,6,8-tetraen-17-one

C23H29NO2 (351.2198)


   

2,6,6,10-tetramethyl-15-azapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁰]icosa-1(19),13,16(20)-triene-17,18-dione

2,6,6,10-tetramethyl-15-azapentacyclo[11.6.1.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁰]icosa-1(19),13,16(20)-triene-17,18-dione

C23H29NO2 (351.2198)


   

2,6,10-trimethyl-1-(2-methyl-1,3-thiazol-4-yl)trideca-1,5-diene-3,11-diol

2,6,10-trimethyl-1-(2-methyl-1,3-thiazol-4-yl)trideca-1,5-diene-3,11-diol

C20H33NO2S (351.2232)